Noreen Henig

Noreen Henig

Direttore/Membro del Consiglio presso
Lazard Healthcare Acquisition Corp. I
61 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Noreen Roth Henig is currently an Independent Director at Lazard Healthcare Acquisition Corp.
I.
Former positions include Independent Director at Avidity Biosciences, Inc. (2019–2026), Independent Director at Lazard Growth Acquisition Corp.
I (2021–2023), Chief Medical Officer at Kezar Life Sciences, Inc. (2020–2023), Chief Medical Officer at Breath Therapeutics GmbH (2018–2020), Chief Development Officer at ProQR Therapeutics NV (2014–2017), Senior Director-Global Respiratory at Gilead Sciences, Inc. (2011–2014), and Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation (1999–2008).
Education includes an undergraduate degree from Yale University (1987) and a doctorate from Albert Einstein College of Medicine, Inc. (1991).

Posizioni attive di Noreen Henig

SocietàPosizioneInizio
Direttore/Membro del Consiglio -

Precedenti posizioni note di Noreen Henig

SocietàPosizioneFine
AVIDITY BIOSCIENCES, INC. Direttore/Membro del Consiglio 27/02/2026
KEZAR LIFE SCIENCES, INC. Direttore Tecnico/Scientifico/R&S 06/10/2023
LAZARD GROWTH ACQUISITION CORP. I Direttore/Membro del Consiglio 01/02/2023
Direttore Tecnico/Scientifico/R&S 01/03/2020
PROQR THERAPEUTICS N.V. Corporate Officer/Principal 01/11/2017
Vedi nel dettaglio l'esperienza di Noreen Henig

Formazione di Noreen Henig

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

81

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Finance

  1. Mercati
  2. Insiders
  3. Noreen Henig